4517ビオフェルミン製薬

Print Friendly, PDF & Email

会社サイト   有価証券報告書

開示年月日決算期種別連個実予売 上 高営業利益経常利益当期利益配当1Q2Q3Q
2006/05/172006/03年度7,2981,5671,594978320150
2006/05/172006/09中間3,750 93054000160
2006/11/222006/09中間3,8611,0151,04259900160
2006/05/172007/03年度7,400 1,620955420160
2007/05/232007/03年度7,7571,5961,655962520160
2007/05/232007/09中間3,8701,0001,0106000017.50
2007/11/212007/09中間4,1031,0481,0676440017.50
2007/05/232008/03年度7,7001,6001,66098035017.50
2008/05/142008/03年度8,5992,1861,8531,09852017.50
2008/07/282008/061Q2,1965365673340000
2008/05/142008/092Q4,1251,0651,10065000260
2008/10/282008/092Q4,4091,1271,16273200260
2009/01/272008/123Q6,6191,7001,7701,09100260
2008/05/142009/03年度8,3001,8001,8701,100520260
2009/05/142009/03年度8,5392,0862,1541,379640260
2009/07/302009/061Q2,1126907254270000
2009/05/142009/092Q4,2651,0801,12065000300
2009/10/292009/092Q4,3501,2711,29376200300
2010/01/282009/123Q6,4851,7891,8461,08800300
2009/05/142010/03年度8,4001,7901,8701,100600300
2010/05/132010/03年度8,4552,1022,1531,234600300
2010/07/292010/061Q2,1787417814600000
2010/05/132010/092Q4,3771,2701,29576500300
2010/10/272010/092Q4,3831,3171,35979100300
2011/01/282010/123Q6,8031,9952,0731,21200300
2010/05/132011/03年度8,4001,9001,9601,150600300
2011/05/122011/03年度9,0732,4012,4721,412600300
2011/07/282011/061Q2,2327247614480000
2011/05/122011/092Q4,5141,3101,33278500300
2011/10/272011/092Q4,5601,3521,39081900300
2012/01/272011/123Q7,1012,2322,2991,39700300
2011/05/122012/03年度9,1002,3302,3801,400600300
2012/05/102012/03年度9,5032,8932,9551,753800300
2012/07/272012/061Q2,5259459675990000
2012/05/102012/092Q4,6001,3851,41087000300
2012/10/102012/092Q5,0981,7601,7801,09000300
2012/10/262012/092Q5,0981,7651,7891,09900300
2013/01/302012/123Q7,6732,5982,6531,64400300
2012/05/102013/03年度9,5502,8102,8601,760600300
2012/10/102013/03年度9,8003,0003,0501,850600300
2013/05/092013/03年度10,3093,3853,4242,126600300
2013/07/262013/061Q2,6631,0471,0826700000
2013/05/092013/092Q5,1251,8201,8551,15000300
2013/10/302013/092Q5,0091,7731,8091,12100300
2014/01/292013/123Q8,4903,2263,2982,04400300
2013/05/092014/03年度10,3503,0003,0601,900600300
2014/05/092014/03年度10,5323,2113,2962,162600300
2014/07/252014/061Q2,9041,1011,1807590000
2014/05/092014/092Q5,4241,7501,7801,15000300
2014/10/292014/092Q5,8882,1352,2131,42500300
2015/01/282014/123Q8,7203,0743,1832,04900300
2014/05/092015/03年度10,6002,9503,0001,950600300
2014/10/292015/03年度10,8003,0503,1402,000600300
2015/05/112015/03年度10,8453,3653,4682,275600300
2015/07/272015/061Q2,6939009416490000
2015/05/112015/092Q5,1221,4501,4901,00000300
2015/10/282015/092Q5,4241,7151,7451,18200300
2016/02/032015/123Q7,1511,8421,8971,30200300
2015/05/112016/03年度10,5002,9003,0002,000600300
2016/02/032016/03年度9,6002,2002,3001,560600300
2016/05/132016/03年度9,6662,2782,3261,589600300
2016/07/292016/061Q2,5617297595290000
2016/05/132016/092Q4,9491,2001,25086000300
2016/10/282016/092Q5,1101,3071,32892600300
2017/01/312016/123Q8,1112,2822,3421,63200300
2016/05/132017/03年度10,3002,3502,4001,700600300
2017/05/122017/03年度10,6182,6982,7091,899850300
2017/07/282017/061Q3,0131,1201,1488000000
2017/05/122017/092Q5,7201,5651,5851,12500300
2017/10/272017/092Q5,8941,8981,9191,33700300
2018/01/302017/123Q8,4682,5952,6071,81600300
2017/05/122018/03年度10,6202,7002,7301,900600300
2018/05/102018/03年度10,8773,1923,1082,210600300
2018/07/262018/061Q2,9031,0991,1337930000
2018/05/102018/092Q5,4351,6751,6801,18000300
2018/10/242018/092Q5,7691,9541,9861,39000300
2019/01/292018/123Q8,6542,4552,5291,77100300
2018/05/102019/03年度11,0253,2703,2802,300600300
2019/05/092019/03年度11,5423,1863,2732,305600300
2019/07/232019/061Q2,7756436794820000
2019/05/092019/092Q5,8601,3001,31592000300
2019/10/292019/092Q6,2231,5771,6091,14400300
2020/01/292019/123Q9,3302,7682,8382,01600300
2019/05/092020/03年度11,7002,4802,5101,760600300
2020/01/292020/03年度11,9502,8002,8502,050600300
2020/05/122020/03年度11,9243,0683,1392,240600300
2020/07/222020/061Q2,9559129506830000
2020/05/122020/092Q5,3101,0451,08075000300
2020/10/222020/092Q5,3661,4471,4841,06700300
2021/01/212020/123Q8,1192,1392,2001,58300300
2020/05/122021/03年度10,9202,1802,2501,560600300
2021/05/122021/03年度10,8112,0582,1201,548600300
2021/07/282021/061Q2,7058558946460000
2021/05/122021/092Q5,4001,1901,23088000300
2021/05/122022/03年度11,1001,9702,0401,460600300

株式交換により大正製薬ホールディングスの完全子会社化されたため2021/7に上場廃止